Literature DB >> 19321583

Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women.

Mireia Junyent1, Donna K Arnett, Michael Y Tsai, Edmond K Kabagambe, Robert J Straka, Michael Province, Ping An, Chao-Qiang Lai, Laurence D Parnell, Jian Shen, Yu-Chi Lee, Ingrid Borecki, Jose M Ordovás.   

Abstract

The scaffolding protein PDZ domain containing 1 (PDZK1) regulates the HDL receptor scavenger receptor class B type I. However, the effect of PDZK1 genetic variants on lipids and metabolic syndrome (MetS) traits remains unknown. This study evaluated the association of 3 PDZK1 single nucleotide polymorphisms (SNP) (i33968C > T, i15371G > A, and i19738C > T) with lipids and risk of MetS and their potential interactions with diet. PDZK1 SNP were genotyped in 1000 participants (481 men, 519 women) included in the Genetics of Lipid Lowering Drugs and Diet Network study. Lipoprotein subfractions were measured by proton NMR spectroscopy and dietary intake was estimated using a validated questionnaire. The PDZK1_i33968C > T polymorphism was associated with MetS (P = 0.034), mainly driven by the association of the minor T allele with higher plasma triglycerides (P = 0.004) and VLDL (P = 0.021), and lower adiponectin concentrations (P = 0.022) than in participants homozygous for the major allele (C). We found a significant gene x BMI x diet interaction, in which the deleterious association of the i33968T allele with MetS was observed in obese participants with high PUFA and carbohydrate (P-values ranging from 0.004 to 0.020) intakes. Conversely, a there was a protective effect in nonobese participants with high PUFA intake (P < 0.05). These findings suggest that PDZK1_i33968C > T genetic variants may be associated with a higher risk of exhibiting MetS. This gene x BMI x diet interaction offers the potential to identify dietary and other lifestyle changes that may obviate the onset of MetS in individuals with a specific genetic background.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321583      PMCID: PMC2714388          DOI: 10.3945/jn.108.101196

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  42 in total

Review 1.  The metabolic syndrome: the crossroads of diet and genetics.

Authors:  Helen M Roche; Catherine Phillips; Michael J Gibney
Journal:  Proc Nutr Soc       Date:  2005-08       Impact factor: 6.297

Review 2.  The changing roles of dietary carbohydrates: from simple to complex.

Authors:  Amy E Griel; Elizabeth H Ruder; Penny M Kris-Etherton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06-22       Impact factor: 8.311

3.  Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study.

Authors:  Frances E Thompson; Amy F Subar; Charles C Brown; Albert F Smith; Carolyn O Sharbaugh; Jared B Jobe; Beth Mittl; James T Gibson; Regina G Ziegler
Journal:  J Am Diet Assoc       Date:  2002-02

Review 4.  Essential fatty acids in health and chronic disease.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

5.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.

Authors:  Frank B Hu; Leslie Bronner; Walter C Willett; Meir J Stampfer; Kathryn M Rexrode; Christine M Albert; David Hunter; JoAnn E Manson
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

6.  Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.

Authors:  Miranda Van Eck; Menno Hoekstra; Ruud Out; I Sophie T Bos; J Kar Kruijt; Reeni B Hildebrand; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2007-10-22       Impact factor: 5.922

7.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.

Authors:  Olivier Kocher; Ayce Yesilaltay; Ching-Hung Shen; Songwen Zhang; Kathleen Daniels; Rinku Pal; Jianzhu Chen; Monty Krieger
Journal:  Biochim Biophys Acta       Date:  2008-03-10

8.  Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.

Authors:  Michael Y Tsai; Angeliki Georgopoulos; James D Otvos; Jose M Ordovas; Naomi Q Hanson; James M Peacock; Donna K Arnett
Journal:  Clin Chem       Date:  2004-05-13       Impact factor: 8.327

Review 9.  n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease.

Authors:  Lucy M Browning
Journal:  Proc Nutr Soc       Date:  2003-05       Impact factor: 6.297

10.  Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization.

Authors:  Sara A Fenske; Ayce Yesilaltay; Rinku Pal; Kathleen Daniels; Attilio Rigotti; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Fatty acid interactions with genetic polymorphisms for cardiovascular disease.

Authors:  Caren E Smith; José M Ordovás
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

2.  Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study.

Authors:  Mireia Junyent; Laurence D Parnell; Chao-Qiang Lai; Yu-Chi Lee; Caren E Smith; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael Province; Ping An; Ingrid Borecki; José M Ordovás
Journal:  Am J Clin Nutr       Date:  2009-07-15       Impact factor: 7.045

3.  "The metabolic syndrome... is dead": these reports are an exaggeration.

Authors:  Alexander Tenenbaum; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2011-01-27       Impact factor: 9.951

4.  Association between ESR1 rs1884051 polymorphism and dietary total energy and plant protein intake on obesity in Korean men.

Authors:  Miae Doo; Yangha Kim
Journal:  Nutr Res Pract       Date:  2011-12-31       Impact factor: 1.926

5.  SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma.

Authors:  Yeon-Su Lee; Bo Hyun Kim; Byung Chul Kim; Aesun Shin; Jin Sook Kim; Seung-Hyun Hong; Jung-Ah Hwang; Jung Ahn Lee; Seungyoon Nam; Sung Hoon Lee; Jong Bhak; Joong-Won Park
Journal:  Oncotarget       Date:  2015-06-30

6.  Relationship between heavy drinking, binge drinking, and metabolic syndrome in obese and non-obese Korean male adults.

Authors:  Jung Eun Oh
Journal:  Nutr Res Pract       Date:  2018-03-22       Impact factor: 1.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.